Related Experiment Video
Updated: Jun 2, 2026

Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Central nervous system bleeding in patients with rare bleeding disorders
S M Siboni1, E Zanon, G Sottilotta
1Centro Emofilia e Trombosi A Bianchi Bonomi, Dipartimento di Medicina Interna e Specialità Mediche, Fondazione IRCCS Cà Granda Ospedale Maggiore Policlinico di Milano, Università degli Studi di Milano, Milano, Italy. simona.siboni@unimi.it
Central nervous system (CNS) bleeding is a serious complication in rare bleeding disorders (RBDs). Recurrence is frequent, highlighting the need for early prophylactic treatment in some patients.
Area of Science:
- Hematology
- Neurology
- Rare Diseases
Background:
- Central nervous system (CNS) bleeding is a severe complication in patients with rare bleeding disorders (RBDs).
- Understanding the epidemiology and outcomes of CNS bleeding in RBDs is crucial for patient management.
Purpose of the Study:
- To retrospectively analyze the incidence, recurrence, mortality, and neurological sequelae of CNS bleeding in patients with RBDs.
- To evaluate the efficacy of treatments, including replacement therapy and surgery, for CNS bleeding in RBDs.
- To identify risk factors and optimal management strategies for CNS bleeding in RBDs.
Main Methods:
- Retrospective data collection on patients with RBDs experiencing CNS bleeding.
- Analysis of demographic data, bleeding characteristics, treatment interventions, and patient outcomes.
- Categorization of bleeding location, type, and onset, alongside assessment of recurrence and neurological sequelae.
Main Results:
- 36 CNS bleeding episodes were analyzed in 24 patients with severe deficiencies in Factors V, X, VII, or XIII.
- Recurrence of CNS bleeding occurred in 25% of patients, with 29% experiencing early onset before age two.
- Intracerebral bleeding was the most common type (53%), with no recorded deaths; 71% of patients received secondary prophylaxis.
Conclusions:
- Recurrence of CNS bleeding is relatively common in severe Factor V, X, VII, and XIII deficiencies.
- Replacement therapy is the primary treatment, with surgery reserved for severe cases; early prophylaxis may be necessary for certain RBDs.
- Further research is needed to optimize prophylactic treatment strategies, including dosage and frequency, for CNS bleeding in RBDs.
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Venous Thrombosis IV: Nursing Management
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...

